We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Novo Nordisk | NYSE:NVO | NYSE | Common Stock |
Price Change | % Change | Share Price | |
---|---|---|---|
-1.02 | -0.82% | 123.00 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
123.77 | 121.2902 | 123.06 | 5,932,928 | 01:00:00 |
Date | Time | Source | Headline |
---|---|---|---|
08/1/2024 | 13:45 | IHNW | Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs |
23/11/2023 | 18:56 | DJN | Wegovy-Maker Novo Nordisk to Spend More Than $2 Billion Boosting Production.. |
15/11/2023 | 14:50 | DJN | Germany Could Consider Banning Ozempic Drug Export, Der Spiegel Reports |
13/11/2023 | 09:11 | DJN | Novo Nordisk's Wegovy Shows Heart Benefits Beyond Weight Loss, New Data.. |
10/11/2023 | 08:40 | DJN | Wegovy Maker Novo Nordisk to Spend $6 Billion Boosting Production Capacity.. |
10/11/2023 | 07:24 | DJN | Novo Nordisk Invests Over $6 Billion to Boost Production Capacity |
02/11/2023 | 07:51 | DJN | Novo Nordisk Earnings Continue to Surge on Blockbuster Weight-Loss Drug.. |
02/11/2023 | 07:11 | DJN | Novo Nordisk Continues to Limit Supply of Blockbuster Weight-Loss Drug |
30/10/2023 | 12:45 | IHNW | Can Diabetes, Weight-Loss Drugs Get Even Better? |
20/10/2023 | 17:14 | DJN | Eli Lilly, Novo Nordisk Test Weight-Loss Shots in Younger Patients,.. |
1 Year Novo Nordisk Chart |
Intraday Novo Nordisk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions